← Back
Data updated: Mar 29, 2026
CHIESI FARMACEUTICI SPA
RespiratoryDermatologyCardiovascular
Biotech
CHIESI FARMACEUTICI SPA is a biotechnology company focused on Respiratory, Dermatology, Cardiovascular. Key products include MYALEPT.
2014
Since
3
Drugs
-
Trials
1
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 93%
0 drugs Phase 3: 16 Phase 2: 14 Phase 1: 26
Dermatology 3%
0 drugs Phase 3: 1
Cardiovascular 3%
0 drugs Phase 3: 1
Gastroenterology 1%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
APOTHECON specialty
Dermatology, Cardiovascular, Gastroenterology, Respiratory
BAUSCH specialty
Dermatology, Cardiovascular, Gastroenterology
COREPHARMA other
Cardiovascular, Respiratory, Gastroenterology, Dermatology
CHIESI big-pharma
Respiratory, Cardiovascular, Dermatology, Gastroenterology
Pfizer big-pharma
Dermatology, Gastroenterology